US Patent 9567386 Therapeutic uses of modified relaxin polypeptides
Patent 9567386 was granted and assigned to Ambrx on February, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+407 characters)
Article
Patent abstract
Modified relaxin polypeptides and their uses, including therapeutic uses thereof for the treatment of a fibrotic disorder or heart failure are provided. Exemplary embodiments provide for the use of relaxin polypeptides which include one or more amino acid substitutions with natural or non-naturally encoded amino acids, and/or linkage to a water-soluble polymer, such as polyethylene glycol.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09567386 Therapeutic uses of modified relaxin polypeptides US Patent 9567386 Therapeutic uses of modified relaxin polypeptides
Infobox
Patent Number
0956738600
Patent Number
956738600
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
095673860
Date of Patent
February 14, 2017
0Patent Application Number
137743490
Date Filed
February 22, 2013
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
095673860
Date of Patent
February 14, 2017
0Patent Application Number
137743490
Date Filed
February 22, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09567386 Therapeutic uses of modified relaxin polypeptides
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09567386
Date of patent
February 14, 2017
Patent application number
13774349
Date Filed
February 22, 2013
Patent primary examiner
Find more entities like US Patent 9567386 Therapeutic uses of modified relaxin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
